3 | SEC Filings Hub

Filing metadata

Accession number: 0000921895-20-002947
Form type: Form 3
Filer: Summit Therapeutics Inc.
CIK: CIK 1599298
Filed: Nov 13, 2020
Reporting period: Nov 11, 2020
Description: Initial ownership

Documents

0000921895-20-002947-index.htm

Complete submission

0000921895-20-002947.txt

directory listing

Filed by

Summit Therapeutics Inc.